Supernus Pharmaceuticals SUPN Stock
$49.89
-2.653660%
Add to favorites
SECTOR
COUNTRY
Exchange
Market Cap
$2.86B
LOW - HIGH [24H]
$49.70
-
$51.38
VOLUME [24H]
$355.73K
P/E Ratio
0
Earnings per share
-$0.34
Supernus Pharmaceuticals Price Chart
Supernus Pharmaceuticals SUPN Financial and Trading Overview
| Supernus Pharmaceuticals stock price | 49.89 USD |
| Previous Close | {summary_details__previousClose} |
| Open | {summary_details__open} |
| Bid | {summary_details__bid} x {summary_details__bidSize} |
| Ask | {summary_details__ask} x {summary_details__askSize} |
| Day's Range | 33.39 - 34.04 USD |
| 52 Week Range | 26.66 - 42.09 USD |
| Volume | {summary_details__volume} |
| Avg. Volume | {summary_details__averageVolume} |
| Market Cap | {summary_details__marketCap} |
| Beta (5Y Monthly) | {summary_details__beta} |
| PE Ratio (TTM) | {summary_details__trailingPE} |
| EPS (TTM) | -0.34 USD |
| Forward Dividend & Yield | {summary_details__dividendRate} ({summary_details__dividendYield}) |
| Ex-Dividend Date | {summary_details__exDividendDate} |
| 1y Target Est | {financial_data__targetMeanPrice} |
SUPN Valuation Measures
| Enterprise Value | {default_key_statistics__enterpriseValue} |
| Trailing P/E | {summary_details__trailingPE} |
| Forward P/E | {summary_details__forwardPE} |
| PEG Ratio (5 yr expected) | {default_key_statistics__pegRatio} |
| Price/Sales (ttm) | {summary_details__priceToSalesTrailing12Months} |
| Price/Book (mrq) | {default_key_statistics__priceToBook} |
| Enterprise Value/Revenue | {default_key_statistics__enterpriseToRevenue} |
| Enterprise Value/EBITDA | {default_key_statistics__enterpriseToEbitda} |
Trading Information
Supernus Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | {default_key_statistics__beta} |
| 52-Week Change | {default_key_statistics__52WeekChange} |
| S&P500 52-Week Change | {default_key_statistics__SandP52WeekChange} |
| 52 Week High | {summary_details__fiftyTwoWeekHigh} |
| 52 Week Low | {summary_details__fiftyTwoWeekLow} |
| 50-Day Moving Average | {summary_details__fiftyDayAverage} |
| 200-Day Moving Average | {summary_details__twoHundredDayAverage} |
SUPN Share Statistics
| Avg. Volume (3 month) | {summary_details__averageVolume} |
| Avg. Daily Volume (10-Days) | {summary_details__averageDailyVolume10Day} |
| Shares Outstanding | {default_key_statistics__sharesOutstanding} |
| Float | {default_key_statistics__floatShares} |
| Short Ratio | {default_key_statistics__shortRatio} |
| % Held by Insiders | {default_key_statistics__heldPercentInsiders} |
| % Held by Institutions | {default_key_statistics__heldPercentInstitutions} |
| Shares Short | {default_key_statistics__sharesShort} |
| Short % of Float | {default_key_statistics__shortPercentOfFloat} |
| Short % of Shares Outstanding | {default_key_statistics__sharesPercentSharesOut} |
Dividends & Splits
| Trailing Annual Dividend Rate | {summary_details__trailingAnnualDividendRate} |
| Trailing Annual Dividend Yield | {summary_details__trailingAnnualDividendYield} |
| 5 Year Average Dividend Yield | {summary_details__fiveYearAvgDividendYield} |
| Payout Ratio | {summary_details__payoutRatio} |
| Last Split Factor | {default_key_statistics__lastSplitFactor} |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | {default_key_statistics__lastFiscalYearEnd} |
| Most Recent Quarter (mrq) | {default_key_statistics__mostRecentQuarter} |
| Next Fiscal Year End | {default_key_statistics__nextFiscalYearEnd} |
Profitability
| Profit Margin | {financial_data__profitMargins} |
| Operating Margin (ttm) | {financial_data__operatingMargins} |
| Gross Margin | {financial_data__grossMargins} |
| EBITDA Margin | {financial_data__ebitdaMargins} |
Management Effectiveness
| Return on Assets (ttm) | {financial_data__returnOnAssets} |
| Return on Equity (ttm) | {financial_data__returnOnEquity} |
Income Statement
| Revenue (ttm) | {financial_data__totalRevenue} |
| Revenue Per Share (ttm) | {financial_data__revenuePerShare} |
| Quarterly Revenue Growth (yoy) | {financial_data__revenueGrowth} |
| Gross Profit (ttm) | {financial_data__grossProfits} |
| EBITDA | {financial_data__ebitda} |
| Net Income Avi to Common (ttm) | {default_key_statistics__netIncomeToCommon} |
| Diluted EPS (ttm) | {default_key_statistics__trailingEps} |
| Quarterly Earnings Growth (yoy) | {default_key_statistics__earningsQuarterlyGrowth} |
Balance Sheet
| Total Cash (mrq) | {financial_data__totalCash} |
| Total Cash Per Share (mrq) | {financial_data__totalCashPerShare} |
| Total Debt (mrq) | {financial_data__totalDebt} |
| Total Debt/Equity (mrq) | {financial_data__debtToEquity} |
| Current Ratio (mrq) | {financial_data__currentRatio} |
| Book Value Per Share (mrq) | {default_key_statistics__bookValue} |
Cash Flow Statement
| Operating Cash Flow (ttm) | {financial_data__operatingCashflow} |
| Levered Free Cash Flow (ttm) | {financial_data__freeCashflow} |
Profile of Supernus Pharmaceuticals
| Country | United States |
| State | {summary_profile__state} |
| City | {summary_profile__city} |
| Address | {summary_profile__address1} |
| ZIP | {summary_profile__zip} |
| Phone | {summary_profile__phone} |
| Website | {summary_profile__website} |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | {summary_profile__fullTimeEmployees} |
{summary_profile__longBusinessSummary}
Q&A For Supernus Pharmaceuticals Stock
What is a current SUPN stock price?
Supernus Pharmaceuticals SUPN stock price today per share is 49.89 USD.
How to purchase Supernus Pharmaceuticals stock?
You can buy SUPN shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Supernus Pharmaceuticals?
The stock symbol or ticker of Supernus Pharmaceuticals is SUPN.
Which industry does the Supernus Pharmaceuticals company belong to?
The Supernus Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Supernus Pharmaceuticals have in circulation?
The max supply of Supernus Pharmaceuticals shares is 57.34M.
What is Supernus Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Supernus Pharmaceuticals PE Ratio is now.
What was Supernus Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Supernus Pharmaceuticals EPS is -0.34 USD over the trailing 12 months.
Which sector does the Supernus Pharmaceuticals company belong to?
The Supernus Pharmaceuticals sector is Healthcare.
Supernus Pharmaceuticals SUPN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23419.08 USD — |
-0.24
|
6.09B USD — | 23414.83 USD — | 23521.05 USD — | — - | 6.09B USD — |
| US Tech Composite Total Return XCMP | 28797.52 USD — |
-0.24
|
— — | 28792.3 USD — | 28922.91 USD — | — - | — — |
| US Tech US 700 Small Cap Value I NQUS700SCV | 2293.06 USD — |
-0.43
|
— — | 2292.98 USD — | 2304.77 USD — | — - | — — |
| US Tech Global Market Composite NQGM | 2275.19 USD — |
-1.01
|
— — | 2275.19 USD — | 2301.72 USD — | — - | — — |
| US Tech Biotechnology NBI | 5707.25 USD — |
-1.03
|
— — | 5693.75 USD — | 5754.1 USD — | — - | — — |
| US Tech Health Care IXHC | 1187.51 USD — |
-0.86
|
— — | 1185.41 USD — | 1195.34 USD — | — - | — — |
| US Tech Biotechnology Total Retu XNBI | 6208.94 USD — |
-1.03
|
— — | 6194.25 USD — | 6259.9 USD — | — - | — — |
| US Tech US 700 Small Cap Value N NQUS700SCVN | 2607.58 USD — |
-0.42
|
— — | 2607.49 USD — | 2620.9 USD — | — - | — — |
| US Tech US 700 Small Cap Index NQUS700SC | 2634.68 USD — |
-0.65
|
— — | 2634.56 USD — | 2652.33 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}